Financial results - IMUNOPLANT SRL

Financial Summary - Imunoplant Srl
Unique identification code: 17554817
Registration number: J05/1029/2005
Nace: 1729
Sales - Ron
11.889
Net Profit - Ron
2.585
Employee
The most important financial indicators for the company Imunoplant Srl - Unique Identification Number 17554817: sales in 2023 was 11.889 euro, registering a net profit of 2.585 euro and having an average number of employees. Firma isi desfasoara activitatea in domeniul Fabricarea altor articole din hartie si carton n.c.a. having the NACE code 1729.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Imunoplant Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 33.467 7.969 21.372 31.379 39.268 49.442 16.218 17.445 23.882 11.889
Total Income - EUR 33.522 7.971 21.386 31.392 39.269 49.443 16.218 17.445 25.198 12.618
Total Expenses - EUR 26.565 7.615 19.612 30.310 22.249 39.158 31.434 22.388 19.974 9.558
Gross Profit/Loss - EUR 6.957 356 1.774 1.083 17.020 10.285 -15.215 -4.943 5.224 3.059
Net Profit/Loss - EUR 5.952 117 1.132 141 15.949 9.054 -15.700 -5.466 4.522 2.585
Employees 1 1 1 0 0 0 0 0 0 0
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales decreased by -50.1%, from 23.882 euro in the year 2022, to 11.889 euro in 2023. The Net Profit decreased by -1.923 euro, from 4.522 euro in 2022, to 2.585 in the last year.

Check the financial reports for the company - Imunoplant Srl

Rating financiar

Financial Rating -
Imunoplant Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Imunoplant Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Imunoplant Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Imunoplant Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Imunoplant Srl - CUI 17554817

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 5.333 180 16.412 21.950 38.719 29.029 15.713 6.746 631 0
Current Assets 7.860 8.604 14.022 13.756 25.867 38.079 39.185 42.824 36.326 38.479
Inventories 508 1.378 3.861 529 803 1.042 0 0 0 0
Receivables 6.558 5.641 9.990 13.404 24.019 34.545 37.987 42.319 35.775 38.302
Cash 794 1.584 171 -176 1.044 2.492 1.198 505 552 177
Shareholders Funds 6.761 6.935 7.996 8.002 23.804 32.398 16.100 10.277 14.830 17.406
Social Capital 67 67 67 66 64 63 79 77 77 77
Debts 10.478 9.428 22.438 27.705 40.781 35.150 39.229 39.714 22.127 21.483
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "1729 - 1729"
CAEN Financial Year 8710
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 38.479 euro in 2023 which includes Inventories of 0 euro, Receivables of 38.302 euro and cash availability of 177 euro.
The company's Equity was valued at 17.406 euro, while total Liabilities amounted to 21.483 euro. Equity increased by 2.620 euro, from 14.830 euro in 2022, to 17.406 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Imunoplant Srl

Comments - Imunoplant Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.